They’ve actually had boards with some of the most weight of any oz bio in several different restructures over the life of the company and it still comes up in too hard basket. Heaps of heavy weight ex big pharma in the upper roles of the board and they still haven’t been able to crack it. Ex VP’s of Bristol Myers Squibb, Scherring, Pfizer Boehringer Ingleheim ..... yet they come and go.
But yes of course this time might be different
Ann: FPP Results Effective in Delivering Peptide Cancer Vaccine, page-70
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.30 |
Change
-0.025(1.89%) |
Mkt cap ! $755.3M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.32 | $1.30 | $478.1K | 365.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |